Company News in the Life Science Industry
Vigil Reports Increased Sales Bookings in First Quarter |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 17 Aug 2019 |
| Related companies: Vigil Health Solutions Inc. |
2019 Overview of the Increasing Use of Medical Imaging Modalities for Guidance and Navigation During Surgical Procedures and Treatments |
DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The Read more ›› |
| By: PR Newswire Association LLC. - 17 Aug 2019 |
Savii Inc. Announces New Client Link Home Care out of NY |
TAMPA, Fla., Aug. 16, 2019 /PRNewswire/ -- Link Home Care Services, cutting-edge LHCSA and CDPAP provider out of New York, selects Savii Inc. as their home care software platform. Their partnership formed due to shared values and desire to drive innovation in the home care industry. |
| By: PR Newswire Association LLC. - 17 Aug 2019 |
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
| Related companies: Apellis Pharmaceuticals, Inc. |
Parent-Targeted Interventions in the Primary Care Setting Improve Parent Communications with Teens about Alcohol Use, Sexual Behavior |
PHILADELPHIA, Aug. 16, 2019 /PRNewswire/ -- New research shows that brief parent-targeted interventions in the primary care setting can increase communication between parents and their teens about sexual and alcohol behavior. This method may serve as an important strategy for parents to influence... Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
| Related companies: Children's Hospital of Philadelphia |
Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15 |
STOCKHOLM, Aug. 16, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today the acceptance of an oral late breaking presentation providing updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study as well as two poster presentations at the 17th International... Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
Immunoassay Markets, 2025 - Increasing Use of Immunoassays in Oncology |
DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
Dr. Susan J. Littman, M.D., is recognized by Continental Who's Who |
AMBLER, Pa., Aug. 16, 2019 /PRNewswire/ -- Dr. Susan J. Littman, M.D., is recognized by Continental Who's Who as a Top Doctor for her outstanding contributions in the field of Medicine. She currently serves as an Internist, Hematologist and Oncologist at Crozer Medical Center. |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
China Precision Medicine Market, 2019-2029: Stakeholder-focused Strategies to Enable Global Partnerships and Overall Industry Growth |
DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device |
MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The FDA's... Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
| Related companies: U.S. Food and Drug Administration | CVRx, Inc. |
FDA approves new device to improve symptoms in patients with advanced heart failure |
SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization... Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
| Related companies: U.S. Food and Drug Administration |
AllianceRx Walgreens Prime Issues Updated List of New Specialty Drugs |
ORLANDO, Fla., Aug. 16, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies... Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 |
HOUSTON, Aug. 16, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its financial results for the second quarter... Read more ›› |
| By: PR Newswire Association LLC. - 16 Aug 2019 |
| Related companies: Moleculin Biotech, Inc. |
Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
| Related companies: Nabriva Therapeutics plc |
Announcement from Acarix's extra general meeting |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
| Related companies: Acarix AB |
Auxly Reports Q2 2019 Financial Results and Subsequent Financing Activities of Over $200 Million |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
| Related companies: T2 Biosystems, Inc. |
Catalyst Biosciences to Present at the 2019 Hemophilia Drug Development Summit |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
| Related companies: Catalyst Biosciences |
Forbes Recognizes PharmCo Rx for its Expertise in CBD Products |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
Protech Home Medical Receives Final Garnishee Order Absolute |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |